Please use this identifier to cite or link to this item: http://ir.mu.ac.ke:8080/jspui/handle/123456789/7819
Title: A case of refractory thrombotic thrombocytopenic purpura treated with plasmapheresis and rituximab
Authors: Kirui, N
Sokwala, A
Keywords: Thrombotic thrombocytopenic purpura
Life-threatening disorder
Issue Date: 17-Mar-2016
Publisher: SAMJ
Abstract: Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disorder with no prevalence or incidence studies in sub-Saharan Africa. Acquired TTP has several causes, all of which lead to decreased activity of von Willebrand factor cleaving protease (ADAMTS13) due to autoantibodies that are directed towards ADAMTS13. We report a case of a 46-year-old man who presented with most of the classic clinical manifestations of TTP.
URI: http://ir.mu.ac.ke:8080/jspui/handle/123456789/7819
Appears in Collections:School of Medicine

Files in This Item:
File Description SizeFormat 
NICHOLAS.pdf121.81 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.